These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 38978013)

  • 1. Antibacterial and antibiofilm potentials of vancomycin-loaded niosomal drug delivery system against methicillin-resistant Staphylococcus aureus (MRSA) infections.
    Hemmati J; Chiani M; Asghari B; Roshanaei G; Soleimani Asl S; Shafiei M; Arabestani MR
    BMC Biotechnol; 2024 Jul; 24(1):47. PubMed ID: 38978013
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Surface modified niosomal quercetin with cationic lipid: an appropriate drug delivery system against Pseudomonas aeruginosa Infections.
    Hemmati J; Chiani M; Chegini Z; Seifalian A; Arabestani MR
    Sci Rep; 2024 Jun; 14(1):13362. PubMed ID: 38862754
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preparation and optimization of ciprofloxacin encapsulated niosomes: A new approach for enhanced antibacterial activity, biofilm inhibition and reduced antibiotic resistance in ciprofloxacin-resistant methicillin-resistance Staphylococcus aureus.
    Mirzaie A; Peirovi N; Akbarzadeh I; Moghtaderi M; Heidari F; Yeganeh FE; Noorbazargan H; Mirzazadeh S; Bakhtiari R
    Bioorg Chem; 2020 Oct; 103():104231. PubMed ID: 32882442
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synergistic effect of curcumin-Cu and curcumin-Ag nanoparticle loaded niosome: Enhanced antibacterial and anti-biofilm activities.
    Targhi AA; Moammeri A; Jamshidifar E; Abbaspour K; Sadeghi S; Lamakani L; Akbarzadeh I
    Bioorg Chem; 2021 Oct; 115():105116. PubMed ID: 34333420
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vancomycin-gingerol encapsulated niosomal formulation against carbapenem-resistant
    Karbalaeiheidar H; Ashrafi F
    Biomed Mater; 2023 May; 18(4):. PubMed ID: 37187182
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel two-chain fatty acid-based lipids for development of vancomycin pH-responsive liposomes against
    Makhathini SS; Kalhapure RS; Jadhav M; Waddad AY; Gannimani R; Omolo CA; Rambharose S; Mocktar C; Govender T
    J Drug Target; 2019 Dec; 27(10):1094-1107. PubMed ID: 30901236
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Niosomal entrapment improved the bactericidal properties of azithromycin against methicillin-resistant
    De Guzman GQ; Dg Yap CD; Dc Munarriz AP; Dimaano AD; C De Guzman LM
    Ther Deliv; 2022 Aug; 13(8):391-402. PubMed ID: 36408615
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of cefazolin-containing niosome nanoparticles against methicillin-resistant Staphylococcus aureus biofilm formed on chronic wounds.
    Zafari M; Adibi M; Chiani M; Bolourchi N; Barzi SM; Shams Nosrati MS; Bahari Z; Shirvani P; Noghabi KA; Ebadi M; Rahimirad N; Shafiei M
    Biomed Mater; 2021 Mar; 16(3):035001. PubMed ID: 33650546
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibacterial and biofilm-inhibitory effects of vancomycin-loaded mesoporous silica nanoparticles on methicillin-resistant staphylococcus aureus and gram-negative bacteria.
    Memar MY; Yekani M; Farajnia S; Ghadiri Moghaddam F; Nabizadeh E; Sharifi S; Maleki Dizaj S
    Arch Microbiol; 2023 Mar; 205(4):109. PubMed ID: 36884153
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel formulation of antimicrobial peptides enhances antimicrobial activity against methicillin-resistant Staphylococcus aureus (MRSA).
    Faya M; Hazzah HA; Omolo CA; Agrawal N; Maji R; Walvekar P; Mocktar C; Nkambule B; Rambharose S; Albericio F; de la Torre BG; Govender T
    Amino Acids; 2020 Oct; 52(10):1439-1457. PubMed ID: 33074344
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Self-assembled oleylamine grafted hyaluronic acid polymersomes for delivery of vancomycin against methicillin resistant Staphylococcus aureus (MRSA).
    Walvekar P; Gannimani R; Salih M; Makhathini S; Mocktar C; Govender T
    Colloids Surf B Biointerfaces; 2019 Oct; 182():110388. PubMed ID: 31369955
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduced vancomycin susceptibility in an in vitro catheter-related biofilm model correlates with poor therapeutic outcomes in experimental endocarditis due to methicillin-resistant Staphylococcus aureus.
    Abdelhady W; Bayer AS; Seidl K; Nast CC; Kiedrowski MR; Horswill AR; Yeaman MR; Xiong YQ
    Antimicrob Agents Chemother; 2013 Mar; 57(3):1447-54. PubMed ID: 23295925
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potentiality of Melittin-Loaded Niosomal Vesicles Against Vancomycin-Intermediate
    Sangboonruang S; Semakul N; Obeid MA; Ruano M; Kitidee K; Anukool U; Pringproa K; Chantawannakul P; Ferro VA; Tragoolpua Y; Tragoolpua K
    Int J Nanomedicine; 2021; 16():7639-7661. PubMed ID: 34819727
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fabrication and optimization of amoxicillin-loaded niosomes: an appropriate strategy to increase antimicrobial and anti-biofilm effects against multidrug-resistant
    Shadvar P; Mirzaie A; Yazdani S
    Drug Dev Ind Pharm; 2021 Oct; 47(10):1568-1577. PubMed ID: 35007176
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibacterial and antibiofilm activities of zingerone and niosomal zingerone against methicillin-resistant
    Larijanian L; Shafiei M; Ghasemi Pirbalouti A; Ferdousi A; Chiani M
    Iran J Microbiol; 2024 Jun; 16(3):366-375. PubMed ID: 39005609
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel chitosan-based pH-responsive lipid-polymer hybrid nanovesicles (OLA-LPHVs) for delivery of vancomycin against methicillin-resistant Staphylococcus aureus infections.
    Hassan D; Omolo CA; Fasiku VO; Mocktar C; Govender T
    Int J Biol Macromol; 2020 Mar; 147():385-398. PubMed ID: 31926237
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of ZnO nanoparticles on methicillin, vancomycin, linezolid resistance and biofilm formation in Staphylococcus aureus isolates.
    Abdelraheem WM; Khairy RMM; Zaki AI; Zaki SH
    Ann Clin Microbiol Antimicrob; 2021 Aug; 20(1):54. PubMed ID: 34419054
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of Imipenem-containing Niosome nanoparticles against high prevalence methicillin-resistant Staphylococcus Epidermidis biofilm formed.
    Piri-Gharaghie T; Jegargoshe-Shirin N; Saremi-Nouri S; Khademhosseini SH; Hoseinnezhad-Lazarjani E; Mousavi A; Kabiri H; Rajaei N; Riahi A; Farhadi-Biregani A; Fatehi-Ghahfarokhi S
    Sci Rep; 2022 Mar; 12(1):5140. PubMed ID: 35332241
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Azithromycin-loaded liposomes for enhanced topical treatment of methicillin-resistant Staphyloccocus aureus (MRSA) infections.
    Rukavina Z; Šegvić Klarić M; Filipović-Grčić J; Lovrić J; Vanić Ž
    Int J Pharm; 2018 Dec; 553(1-2):109-119. PubMed ID: 30312749
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Encapsulation of collagen mimetic peptide-tethered vancomycin liposomes in collagen-based scaffolds for infection control in wounds.
    Thapa RK; Kiick KL; Sullivan MO
    Acta Biomater; 2020 Feb; 103():115-128. PubMed ID: 31843720
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.